The FDA has issued draft guidance that would give certain Class I and Class II in vitro diagnostic and radiology devices a reprieve from the 510(k) clearance process. The FDA will use discretion in applying submission guidelines for those devices as it finalizes the proposed exemptions and classification downgrades.

Related Summaries